uniQure N.V. Stock Forecast
NASDAQ: QUREHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
QURE analyst consensus
Consensus (12 analysts)
strong_buy
Avg. price target
$62.33+175.92%
- Strong buy 1
- Buy 9
- Hold 2
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 12 Wall Street analysts covering uniQure N.V. (2026-10-07), 10 rate the stock a buy or strong buy, 2 rate it a hold and 0 rate it a sell or strong sell, for a consensus rating of "strong_buy". The average 12-month price target is $62.33, with a high estimate of $91.51 and a low estimate of $27.98. The average target implies upside of 175.9% from the current price of $22.59.
The spread between the highest and lowest targets is 227.1%, a wide range that reflects significant disagreement among analysts. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for QURE.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 1 | 8% |
| Buy | 9 | 75% |
| Hold | 2 | 17% |
| Sell | 0 | 0% |
| Strong sell | 0 | 0% |
Ratings as of 2026-10-07.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $27.98 | +23.86% |
| Average target | $62.33 | +175.92% |
| High target | $91.51 | +305.09% |